Navigation Links
Inclinix, Inc. Announces Executive Management Team Changes
Date:2/22/2008

WILMINGTON, N.C., Feb. 22 /PRNewswire/ -- Inclinix, Inc., an enrollment contract research organization (CRO) and provider of clinical trial recruitment solutions, announced today the following changes to its executive management team:

-- Steven M. Agnoff, has joined the company in the position of Vice

President of Marketing and Product Management. In this role, Mr. Agnoff

provides strategic direction to the corporate marketing and product

marketing functions of the company and oversees product management

efforts. Prior to joining Inclinix, Mr. Agnoff held executive

leadership and business development roles with organizations including

PDI, Inc., PharmaKon, Fenner PLC, Efson, Inc. and Interroll

Corporation.

-- Daniel D. Marks, has joined the company as Vice President of Corporate

Development. In this role, Mr. Marks is responsible for the evaluation

and execution of Inclinix's strategic investments, joint ventures and

acquisitions. Before joining Inclinix, he held executive management

roles within the technology and medical services sectors.

-- Jeffrey L. Bagshaw, has been named Senior Vice President of Sales. In

this role, Mr. Bagshaw is responsible for leading sales operations of

Inclinix. Prior to this role, he served as vice president of medical

marketing and communications at Inclinix. Prior to joining Inclinix,

Mr. Bagshaw held sales and marketing leadership roles at organizations

including Hoffman La Roche, Bristol Myers Squibb and Exact Sciences.

Newly-reporting to Mr. Bagshaw is:

-- Susan A. Jalbert, who has joined the company as Director of North

American Sales. In this role, Ms. Jalbert has responsibility for

managing strategic client relationship development and tactical sales

efforts with Inclinix's expanded sales team. Prior to joining

Inclinix, Ms. Jalbert held sales and business development leadership

positions at Medidata Solutions, Relsys International, Inc., Domain

Pharma Corporation, Neuromedical Systems, Inc. and the Corning

Nichols Institute. Now reporting to Ms. Jalbert are:

- Ashley Amstutz, sales executive;

- Jeffrey Cazeault, sales executive;

- Svetlana Gorodetsky, sales executive;

- Matt Granger, sales executive;

- Askold Kozbur, sales executive;

- Tom McCollum, senior sales executive;

- Stephen Scaldaferri, sales executive; and

- Christine Ward, sales executive.

CEO and President J. Tobin Geatz said: "We are excited to have these accomplished industry professionals on board to strengthen our leadership team. Having previously helped other innovative companies accelerate their revenues and growth paths, these executives, without doubt, are equipped and ready to guide Inclinix during this time of tremendous growth."

About Inclinix

Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO. Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplify traditional services and is proven to accelerate trials for pharmaceutical, biotechnology and medical-device organizations. In addition to its clinical research-related offerings, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit http://www.inclinix.com


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HCA Announces Preliminary Results for Its Debt Tender Offer
2. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
3. Air Methods Announces New Chief Operating Officer
4. Pacific Fertility Center Announces Breakthrough in Egg Freezing Technology
5. Neurochem announces departure of two members of management team
6. Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program
7. LCA-Vision Announces Quarterly Dividend Payment
8. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
9. China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
10. IDM Pharma Announces Compliance With NASDAQ Minimum Bid Price Requirements
11. Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... More than half of American teens report ... parents report speaking with their child about sex related topics, less than 60 percent ... is proud to announce the launch of its second edition of the “Sexual Wellness” ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Sourced from the ... some unique properties including its unmatched natural purity of just 6 ppm TDS (Total ... crisp. , Nothing Water has been available in several ShopRite and FoodTown stores in ...
(Date:12/2/2016)... ... December 02, 2016 , ... On ... individuals and families from eight different sites throughout Miami-Dade and Broward counties. This ... volunteers worked very hard on Thanksgiving morning by putting together individual meals via ...
(Date:11/30/2016)... ... November 30, 2016 , ... Northridge ... comprehensive in-house dental plan for all patients. Understanding that budget can play a ... patients a number of perks, including discounts on many valuable dental treatments. Options ...
(Date:11/30/2016)... ... November 30, 2016 , ... In recent policy ... focus of public policymakers and system stakeholders in many states. To help them ... Medical Price Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , “If you ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016   CytoSorbents Corporation (NASDAQ: CTSO ... Union approved CytoSorb ® cytokine adsorber to treat ... announced that Dr. Phillip Chan , Chief Executive ... Micro Main Event investor conference held from December ... Sunset Boulevard Hotel in Los Angeles, California ...
(Date:12/2/2016)... 2016 On Thursday, the NASDAQ Composite ... Jones Industrial Average edged 0.36% higher, to finish at 19,191.93; ... were broad based as six out of nine sectors ended ... on the following Services equities: Myriad Genetics Inc. (NASDAQ: ... INC Research Holdings Inc. (NASDAQ: INCR ), and ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
Breaking Medicine Technology: